Globalization

Looking back, thinking ahead: industry leaders talk trends

16-Dec-2020 By Jenni Spinner

Experts from a variety of research and drug development organizations share their thoughts on highlights from 2020, and predict what 2021 might hold.

2020 was ‘the year our industry got it right’: pharma veteran

16-Dec-2020 By Jenni Spinner

William Carson says while the past year was full of challenges, embracing AI and other advanced technology led to impressive progress and opportunity.

CPhI report looks ahead to post-COVID pharma world

08-Dec-2020 By Jenni Spinner

The industry analysis dives into likely developments in supply chain, impact of the new White House occupant, CDMO growth and other key areas.

Cytel: modern trials could benefit from historical approach

16-Nov-2020 By Jenni Spinner

A leader from the clinical research technology firm shares perspective on the benefits Bayesian trial design, an approach dating back to the 1700s.

People on the Move: November 2020

05-Nov-2020 By Jenni Spinner

The most recent news on pharmaceutical industry hires, promotions, acquisitions and other events includes Lonza, Medidata, Vetter, and Almac Group.

Minakem: CM reaps time-saving, quality-boosting benefits

04-Nov-2020 By Jenni Spinner

Leaders from the CDMO discuss how the surging interest in continuous manufacturing can result in cost savings and numerous other advantages.

DARPA selects continuous manufacturing partner

04-Nov-2020 By Jenni Spinner

The agency has chosen Continuity Pharma to aid in development and advancement of continuous manufacturing technology, with the help of a $1.5m grant.

TraceLink launches intelligent product serialization technology

03-Nov-2020 By Jenni Spinner

The Serialized Product Intelligence application uses serialization data to help operations streamline supply-chain operations, resolve issues and more.

Syneos Health to acquire Synteract

29-Oct-2020 By Jenni Spinner

With the purchase, Syneos Health seeks to strengthen connections with the rapidly growing pre-revenue biopharmaceutical market, and expand global reach.